Agilon Health Inc [AGL] stock prices are up 4.39% to $3.09 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The AGL shares have gain 27.16% over the last week, with a monthly amount glided 41.10%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Agilon Health Inc [NYSE: AGL] stock has seen the most recent analyst activity on January 10, 2025, when Citigroup upgraded its rating to a Neutral and also boosted its price target to $2.25 from $1.75. On December 16, 2024, Macquarie initiated with a Neutral rating. Bernstein started tracking the stock assigning a Mkt Perform rating and suggested a price target of $2.50 on December 11, 2024. JMP Securities downgraded its rating to a Mkt Perform. William Blair downgraded its rating to Mkt Perform for this stock on November 08, 2024. In a note dated October 30, 2024, Citigroup downgraded an Sell rating on this stock and revised its target price from $7 to $2.50.
The stock price of Agilon Health Inc [AGL] has been fluctuating between $1.50 and $7.73 over the past year. Currently, Wall Street analysts expect the stock to reach $3.17 within the next 12 months. Agilon Health Inc [NYSE: AGL] shares were valued at $3.09 at the most recent close of the market. An investor can expect a potential return of 2.59% based on the average AGL price forecast.
Analyzing the AGL fundamentals
The Agilon Health Inc [NYSE:AGL] reported sales of 5.59B for trailing twelve months, representing a surge of 19.35%. Gross Profit Margin for this corporation currently stands at -0.01% with Operating Profit Margin at -0.06%, Pretax Profit Margin comes in at -0.06%, and Net Profit Margin reading is -0.06%. To continue investigating profitability, this company’s Return on Assets is posted at -0.16, Equity is -0.5 and Total Capital is -0.51. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.08.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.93 points at the first support level, and at 2.76 for the second support level. However, for the 1st resistance point, the stock is sitting at 3.27, and for the 2nd resistance point, it is at 3.45.
Ratios To Look Out For
It’s worth pointing out that Agilon Health Inc [NYSE:AGL]’s Current Ratio is 1.29. As well, the Quick Ratio is 1.29, while the Cash Ratio is 0.11. Considering the valuation of this stock, the price to sales ratio is 0.23, the price to book ratio is 2.21.
Transactions by insiders
Recent insider trading involved McLoughlin Karen, Director, that happened on Dec 13 ’24 when 25000.0 shares were purchased. Director, Battaglia Silvana completed a deal on Dec 11 ’24 to buy 25062.0 shares. Meanwhile, Director MCKENZIE DIANA bought 12500.0 shares on Nov 25 ’24.
